Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 5:03 AM
Ignite Modification Date:
2025-12-25 @ 5:03 AM
NCT ID:
NCT00536718
Eligibility Criteria:
DISEASE CHARACTERISTICS:
* Meets 1 of the following criteria:
* Current or prior diagnosis of lobular carcinoma in situ (LCIS) of the breast, including any of the following cases:
* Pure LCIS
* LCIS with subsequent development of invasive breast cancer of any morphological subtype
* LCIS presenting as an incidental finding together with invasive breast cancer of any morphological subtype
* Control participant matched for age and ethnicity to each LCIS patient
* Not affected by LCIS
* No history of ductal carcinoma in situ of the breast
* No breast cancer
* No relative (up to 2nd degree) who has been affected by breast cancer
* Male or female
PATIENT CHARACTERISTICS:
* Not specified
PRIOR CONCURRENT THERAPY:
* Not specified
Healthy Volunteers:
True
Sex:
FEMALE
Maximum Age:
60 Years
Study:
NCT00536718
Study Brief:
Protocol Section:
NCT00536718